[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334083-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334083-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","radioresistance-and-brain-metastases-a-review-of-the-literature-and-applied-perspective","Radioresistance and brain metastases - a review of the literature and applied perspective","","Intracranial metastatic disease is a serious cancer complication treated with surgery, radiation, and targeted therapies, with radiotherapy playing a central role. The review explains why understanding metastatic radioresistance is essential for prognosis and therapeutic development, and how modern delivery techniques require revisiting older clinic-radiographic definitions. It synthesizes radioresistance determinants across tumor-, host-, technical-, and probabilistic-level influences, including hypoxia, cancer stem cells, microenvironment and metabolic changes, DNA damage repair, non-coding RNAs, exosomes, methylation, and autophagy, with discussion framed specifically for brain metastases.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/radioresistance-and-brain-metastases-a-review-of-the-literature-and-applied-perspective/334083/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/radioresistance-and-brain-metastases-a-review-of-the-literature-and-applied-perspective/334083.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is understanding radioresistance in brain metastases important?","Question",{"text":63,"@type":64},"Radiation therapy is central to intracranial metastatic disease treatment. Knowing radioresistance supports prognostication and therapeutic development.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How has the definition of radioresistance changed over time?",{"text":68,"@type":64},"Radioresistance was historically defined by clinic-radiographic tumor response under maximum tolerable doses. Modern stereotactic radiosurgery allows higher doses with less exposure beyond the target, prompting the need to revisit classical definitions.",{"name":70,"@type":61,"acceptedAnswer":71},"What major categories of factors influence radioresistance?",{"text":72,"@type":64},"Tumor-related factors, host-related factors, technical factors, and probabilistic factors influence radioresistance. Additional mechanisms include DNA damage repair pathways, non-coding RNAs, exosomes, methylation, autophagy, and tumor microenvironment effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334083,1790228715,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Review  \nPUBLISHED 30 October 2024 DOI 10.3389/fonc.2024.1477448  \nOPEN ACCESS  \nEDITED BY  \nIra Ida Skvortsova,  \nInnsbruck Medical University, Austria  \nREVIEWED BY  \nConnor Kinslow,  \nColumbia University, United States Satoru Osuka,  \nUniversity of Alabama at Birmingham, United States  \n*CORRESPONDENCE  \nSunit Das  \n [sunit.das@utoronto.ca](sunit.das@utoronto.ca)  \nRECEIVED 08 August 2024  \nACCEPTED 09 October 2024  \nPUBLISHED 30 October 2024  \nCITATION  \nYoussef A, Sahgal A and Das S (2024)  \nRadioresistance and brain metastases: a review of the literature and applied perspective.  \nFront. Oncol. 14:1477448 .  \ndoi: 10.3389/fonc.2024.1477448  \nCOPYRIGHT  \n© 2024 Youssef, Sahgal and Das. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRadioresistance and brain metastases: a review of the literature and applied perspective  \nAndrew Youssef 1, Arjun Sahgal 2 and Sunit Das 3*  \n1 Institute of Medical Science, University of Toronto, Toronto, ON, Canada, 2 Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Hospital, Toronto, ON, Canada, 3 Division of Neurosurgery, St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada  \nIntracranial metastatic disease is a serious complication of cancer, treated through surgery, radiation, and targeted therapies. The central role of radiation therapy makes understanding the radioresistance of metastases a priori a key interest for prognostication and therapeutic development. Although historically deﬁned clinic-radiographically according to tumour response, developments in new techniques for delivering radiation treatment and understanding of radioprotective mechanisms led to a need to revisit the deﬁnition of radioresistance in the modern era. Factors inﬂuencing radioresistance include tumour-related factors (hypoxia, cancer stem cells, tumour kinetics, tumour microenvironment, metabolic alterations, tumour heterogeneity DNA damage repair, non-coding RNA, exosomes, methylomes, and autophagy), host-related factors (volume effect & dose-limiting non-cancerous tissue, pathophysiology, and exosomes), technical factors, and probabilistic factors (cell cycle and random gravity of DNA damage) . Inﬂuences on radioresistance are introduced and discussed in the context of brain metastases.  \nKEYWORDS  \nradiotherapy, cancer, brain, metastases, radioresistance  \n1 Introduction  \n1.1 Intracranial metastatic disease and radiotherapy  \nIntracranial metastatic disease (IMD) is a serious complication of cancer and the most common type of brain tumour (1), estimated to affect roughly 2% of all patients with cancer and compromise 12% of all metastatic sites (2) . IMD has a poor prognosis, which is affected by factors such as the extent of systemic disease, number of intracranial metastases, performance status and age (1, 3) . Treatments for IMD include surgery, radiation and target therapies (4). Radiation therapy (RT) holds a central role in IMD treatment and why  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nunderstanding the radioresistance of a metastases a priori is of key interest in both prognostication and therapeutic development.  \n1.2 History of radiobiology and radioresistance  \nThe effects seen from RT result principally from direct or indirect DNA damage (5) . Direct ionising radiation damage results from DNA ionisation or excitation, leading to a base change. Indirect ionising radiation damage occurs more frequently from RT and occurs when the energy from the RT is transferred to other cellular atoms (namely water) and produces free radicals, which can th","cbCaipcJgy5HZxEL","https://ap.wps.com/l/cbCaipcJgy5HZxEL","pdf",998191,12,"English","# Introduction\n## Intracranial metastatic disease and radiotherapy\n## History of radiobiology and radioresistance\n# Tumour-related factors","[{\"question\":\"Why is understanding radioresistance in brain metastases important?\",\"answer\":\"Radiation therapy is central to intracranial metastatic disease treatment. Knowing radioresistance supports prognostication and therapeutic development.\"},{\"question\":\"How has the definition of radioresistance changed over time?\",\"answer\":\"Radioresistance was historically defined by clinic-radiographic tumor response under maximum tolerable doses. Modern stereotactic radiosurgery allows higher doses with less exposure beyond the target, prompting the need to revisit classical definitions.\"},{\"question\":\"What major categories of factors influence radioresistance?\",\"answer\":\"Tumor-related factors, host-related factors, technical factors, and probabilistic factors influence radioresistance. Additional mechanisms include DNA damage repair pathways, non-coding RNAs, exosomes, methylation, autophagy, and tumor microenvironment effects.\"}]","Radioresistance and brain metastases - a review of the literature and applied perspective | PDF",1790005216]